Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Galega officinalis
A European herb that inspired the development of metformin; guanidine compounds (galegine) reduce blood sugar through AMPK activation; used for diabetes and lactation enhancement.
Galega officinalis, commonly known as goat's rue, is a European herb historically used for diabetes management and as a galactagogue. Its primary active compounds include galegine and guanidine derivatives, which have demonstrated blood sugar-lowering effects through AMPK activation, inspiring the development of metformin. Modern evidence supports its use in type 2 diabetes and lactation support, though clinical data remain limited.
Galegine and related guanidine compounds activate AMP-activated protein kinase (AMPK), enhancing insulin sensitivity and promoting glucose uptake in peripheral tissues. They also inhibit hepatic gluconeogenesis and may improve pancreatic beta-cell function. For lactation, the galactagogue effect is thought to involve prolactin modulation or direct stimulation of mammary tissue, though the precise mechanism is not well established.
A European herb that inspired the development of metformin; guanidine compounds (galegine) reduce blood sugar through AMPK activation; used for diabetes and lactation enhancement.
Galega officinalis, commonly known as goat's rue, is a European herb historically used for diabetes management and as a galactagogue. Its primary active compounds include galegine and guanidine derivatives, which have demonstrated blood sugar-lowering effects through AMPK activation, inspiring the development of metformin. Modern evidence supports its use in type 2 diabetes and lactation support, though clinical data remain limited.
Galegine and related guanidine compounds activate AMP-activated protein kinase (AMPK), enhancing insulin sensitivity and promoting glucose uptake in peripheral tissues. They also inhibit hepatic gluconeogenesis and may improve pancreatic beta-cell function. For lactation, the galactagogue effect is thought to involve prolactin modulation or direct stimulation of mammary tissue, though the precise mechanism is not well established.